Skip to main content
. 2022 Jul 2;22:325. doi: 10.1186/s12876-022-02404-9

Table 3.

EQ-5D-3L mean score comparisons between groups

Field Visit Control group BAD PC CD p Value

Mobility

(MOB)

Before Treatment

1.50

(1.22–1.78)

1.30

(1.10–1.51)

1.36

(1.02–1.70)

1.18

(0.91–1.45)

0.39
After treatment

1.30

(1.06–1.55)

1.55

(1.19–1.89)

1.00

(1.00–1.00)

*0.04
p value p = 1.0 p = 0.34 p = 0.17

Self-care

(SC)

Before treatment

1.25

(0.99–1.51)

1.04

(0.95–1.13)

1.08

(0.90–1.27)

1.09

(0.89–1.29)

0.36
After treatment

1.00

(1.00–1.00)

1.17

(0.91–1.41)

1.00

(1.00–1.00)

0.05
p value p = 0.39 p = 0.34 p = 0.34

Activity

(ACT)

Before treatment

1.67

(1.40–1.94)

2.04

(1.76–2.24)

1.50

(1.07–1.93)

1.45

(1.10–1.81)

*0.04
After treatment

1.52

(1.20–1.80)

1.67

(1.35–1.98)

1.45

(1.10–1.81)

0.65
p value * p = 0.002 p = 0.44 p = 1.0

Pain and Discomfort

(PD)

Before treatment

1.96

(1.72–2.19)

1.96

(1.75–2.16)

1.92

(1.59–2.24)

2.00

(1.47–2.52)

0.99
After treatment

1.78

(1.52–2.04)

2.00

(1.62–2.38)

1.55

(1.08–2.01)

0.23
p value p = 0.16 p = 0.59 p = 0.1

Anxiety and Depression

(AD)

Before treatment

1.79

(1.49–2.10)

1.87

(1.60–2.14)

1.67

(1.35–1.98)

1.91

(1.71–2.11)

0.75
After treatment

1.61

(1.36–1.86)

1.92

(1.41–2.42)

1.64

(1.30–1.98)

0.37
p value p = 0.06 p = 0.19 p = 0.19

Visual Analogue Scale

(VAS)

Before treatment

66.68

(55.89–77.47)

59.23

(48.70–69.85)

54.67

(39.59–69.75)

64.09

(46.17–82.01)

0.53
After treatment

63.14

(54.14–72.14)

59.33

(41.82–76.85)

71.64

(58.25–85.02)

0.41
p value p = 0.48 p = 0.39 p = 0.26

BAD: Bile acid diarrhoea, PC: post-cholecystectomy, CD: terminal ileal resected Crohn’s Disease. 95%CI is represented within parenthesis. p Values on the right-hand column indicate comparison of mean scores between the groups at that specific moment in time. The p values in each row indicate comparison of mean scores between each group before and after treatment. * denotes p < 0.05